Microinfusions of the nonselective muscarinic antagonist scopolamine into perirhinal cortex impairs performance on visual recognition tasks, indicating that muscarinic receptors in this region play a pivotal role in recognition memory. To assess the mnemonic effects of selective blockade in perirhinal cortex of muscarinic receptor subtypes, we locally infused either the m1-selective antagonist pirenzepine or the m2-selective antagonist methoctramine in animals performing one-trial visual recognition, and compared these scores with those following infusions of equivalent volumes of saline. Compared to these control infusions, injections of pirenzepine, but not of methoctramine, significantly impaired recognition accuracy. Further, similar doses of scopolamine and pirenzepine yielded similar deficits, suggesting that the deficits obtained earlier with scopolamine were due mainly, if not exclusively, to blockade of m1 receptors. The present findings indicate that m1 and m2 receptors have functionally dissociable roles, and that the formation of new visual memories is critically dependent on the cholinergic activation of m1 receptors located on perirhinal cells.
Introduction
Visual recognition memory depends on activation of cholinergic muscarinic receptors in the perirhinal cortex, as evidenced by the memory impairment that is produced in both rodents and monkeys by intraperirhinal injections of the muscarinic receptor antagonist scopolamine (Tang, Mishkin, & Aigner, 1997; Warburton et al., 2003) . Furthermore, this drug-induced impairment is known to result from interference with memory storage as opposed to memory retrieval, since scopolamine is effective when administered shortly before stimulus familiarization but not when it is administered in the period between familiarization and test (Aigner, Walker, & Mishkin, 1991) . Although the above findings establish muscarinic receptors as critical players in memory formation, these receptors consist of several different subtypes, and, because scopolamine is a nonselective muscarinic antagonist, it is still unknown which subtypes are the essential ones for the storage of visual memories. The present study aimed to address this issue.
Muscarinic receptors are a non-homogeneous class of G-protein-coupled receptors, composed of five discrete subtypes, m1-m5 (Bonner, 1989; Caulfield, 1993; Wess, 1996) . The five subtypes divide naturally into two groups on the basis of their cellular and molecular effects. One group, M1, consists of the m1, m3, and m5 subtypes, which couple to G q/11 and thereby produce such changes as activation of phospholipase C, increased MAPK activity, and mobilization of intracellular Ca
2+
. The other group, M2, consists of the m2 and m4 subtypes, which couple to G i/o and so induce changes such as inhibition of adenylyl cyclase activity and inactivation of Ca 2+ channels (Eglen, 2006; Ishii & Kurachi, 2006; Lucas-Meunier, Fossier, Baux, & Amar, 2003) . Receptor subtypes m1 and m2 are both abundantly expressed in cerebral cortex, but they differ in their laminar distribution as well as in their synaptic location, m1 being expressed mainly on postsynaptic neurons, and m2, mainly on presynaptic terminals (Alcantara et al., 2001; Levey, 1996; Rouse, Marino, Potter, Conn, & Levey, 1999) . Scopolamine does not discriminate between m1 and m2 subtypes as well as some other compounds do. For example, the muscarinic receptor antagonist pirenzepine was found in one in vitro assay to have a 57-fold greater affinity for the m1 than for the m2 subtype (Buckley, Bonner, Buckley, & Brann, 1989; Hammer, Berrie, Birdsall, Burgen, & Hulme, 1980) , whereas the reverse was the case for the muscarinic receptor antagonist methoctramine, which had an approximately 4.4-fold greater affinity for the m2 than for the m1 receptor subtype (Buckley et al., 1989; Giraldo et al., 1988) . Tinsley and colleagues (2011) recently reported that intraperirhinal injections of pirenzepine impaired visual recognition memory in the rat, but there has been no report on the visual memory effects of similarly infusing a selective m2 antagonist. Here, in a study conducted with monkeys, we attempted to
